CorMedix Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.85 | $157.41 M | -2.5 | 51 | $0 |
ALDX
Aldeyra Therapeutics, Inc. |
$5.27 | $229.34 M | -7.57 | 9 | $0 |
APTO
Aptose Biosciences Inc. |
$0.23 | $16.66 M | -0.15 | 35 | $0 |
CELC
Celcuity Inc. |
$13.17 | $501.59 M | -5.14 | 55 | $0 |
CNTB
Connect Biopharma Holdings Limited |
$1.16 | $108.00 M | -1.81 | 81 | $0 |
ELDN
Eledon Pharmaceuticals, Inc. |
$4.64 | $107.05 M | -2.26 | 20 | $0 |
ELVN
Enliven Therapeutics, Inc. |
$24.07 | $984.95 M | -11.97 | 57 | $0 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
ETON
Eton Pharmaceuticals, Inc. |
$12.16 | $92.74 M | 120.33 | 30 | $31.64 M |
GOSS
Gossamer Bio, Inc. |
$1.09 | $124.06 M | -0.65 | 135 | $0 |
INBX
Inhibrx Biosciences, Inc. |
$16.52 | $241.02 M | -1.44 | 166 | $1.80 M |
KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 | $0 |
LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
MACK
Merrimack Pharmaceuticals, Inc. |
$15.15 | $223.75 M | -168.11 | 0 | $0 |
NUVB
Nuvation Bio Inc. |
$2.84 | $684.66 M | -8.66 | 220 | $7.87 M |
NVCT
Nuvectis Pharma, Inc. |
$6.61 | $116.38 M | -4.5 | 13 | $0 |
PGEN
Precigen, Inc. |
$1.27 | $408.92 M | -4.15 | 202 | $6.23 M |
REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
SGMO
Sangamo Therapeutics, Inc. |
$1.35 | $119.17 M | -0.31 | 405 | $176.23 M |
TARS
Tarsus Pharmaceuticals, Inc. |
$56.20 | $1.22 B | -6.78 | 323 | $182.95 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
TVTX
Travere Therapeutics, Inc. |
$18.71 | $542.80 M | -1.32 | 385 | $233.18 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
